University of Minnesota. Driven to Discover.
High-level groups and vaccine companies say there's enough vaccine, but several obstacles block doses from getting to low- and middle-income countries.
Officials are hopeful Africa can reach 10% of its population with vaccine by the end of September.
The study found extremely high rates of resistance to ampicillin and gentamicin.
The next study phase includes examining raw data and stored blood samples.
Stubbornly high levels persist in nations including Thailand and Vietnam as Delta variant activity keeps countries on edge, from Australia to China.
WHO head Tedros urges Moderna and Pfizer to go all out on channeling vaccine supply to COVAX.
Sixteen African nations report resurgences, and cases have more than doubled in some European countries.
WHO officials said variant spread could outpace vaccines, even in countries with high vaccine coverage.
Study finds that tocilizumab and sarilumab reduce the risk of death and the need for mechanical ventilation.
Both cases and deaths in Africa rise sharply—cases by 33% and deaths by 42%.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2022 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.